Update on rufinamide in childhood epilepsy
Giangennaro CoppolaClinic of Child and Adolescent Neuropsychiatry, Medical School, University of Salerno, ItalyAbstract: Rufinamide is an orally active, structurally novel compound (1-[(2,6-difluorophenil1)methyl1]-1 hydro 1,2,3-triazole-4 carboxamide), which is structurally distinct from other anti...
Main Author: | Coppola G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-07-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/update-on-rufinamide-in-childhood-epilepsy-a7804 |
Similar Items
-
Efficacy and safety of rufinamide in pediatric epilepsy
by: David T. Hsieh, et al.
Published: (2013-05-01) -
Rufinamide
by: S Tandon, et al.
Published: (2010-01-01) -
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
by: Carl E Stafstrom
Published: (2009-10-01) -
EFFICACY OF RUFINAMIDE IN THE TREATMENT OF DRUG-RESISTANT FOCAL EPILEPSIES IN PAEDIATRIC PRACTICE
by: I. O. Shchederkina, et al.
Published: (2017-02-01) -
Efficacy and tolerability of rufinamide in the treatment of epilepsy (experience of the Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: K. Yu. Mukhin, et al.
Published: (2018-11-01)